At a glance
Read the record in context
Tamoxifen's 144-hour input concerns the parent compound. The source explicitly says active metabolites persist longer. That limitation is as important as the number itself: a single card or curve cannot silently stand for every active substance associated with an oral record.[1]
What the research says
The tamoxifen label describes oral pharmacokinetic studies measuring both the parent compound and its metabolites. After a single administration, plasma tamoxifen reached its average peak at about five hours. The subsequent decline had two phases, with a terminal half-life of approximately five to seven days.[2][1]
Repeated-administration studies measured accumulation of tamoxifen and N-desmethyl tamoxifen over months. The metabolite reached a different concentration and persisted longer than the parent. Radiolabeled studies in women also tracked excretion, with feces accounting for the principal elimination route during the observation period.[2]
These measurements show why parent drug and metabolite should not be represented as one identical substance. The library's parent-compound reference simplifies that larger metabolic picture. The cited oral studies support formulation-specific pharmacology, not a peptide-vial amount or an individualized prediction of estrogen-receptor effects.[2][1]
Cited amounts
The library does not supply a typical vial amount for this entry. This guide therefore reports no vial total or human dosing range and does not infer one from the half-life.[1]
Open the calculator for amount conversionsHalf-life and timing
Six days is the midpoint-style scalar represented by 144 hours. Two intervals span 12 days and retain one quarter of the starting quantity; five span 30 days and retain one thirty-second. The parent-compound context is essential throughout that month-long illustration. The source's longer-persisting active metabolites are not additional curves hidden inside the bar. No personal clearance claim follows from the final fraction, and the graph does not add oral absorption or subsequent administrations to its single-input equation.[1][4]
Continue to the calculatorReconstitution
The oral tamoxifen entry has no documented typical vial. Consequently, this guide lacks the mass-and-volume pair needed for a sourced reconstitution example. The parent-compound half-life and metabolite note do not supply package concentration. Inserting an assumed injectable total would create an unsupported presentation rather than clarify the oral record. The general calculator is linked for independently known quantities, while this page confines its numeric illustration to the reference time model and explicitly preserves the missing liquid-package information.[1]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[3]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- Does a tamoxifen half-life chart include its active metabolites?
- This guide reproduces the library's parent-compound input of 144 hours. The source note says active metabolites persist longer. A single parent-compound curve is therefore not a model of every active substance associated with the record.[1][2]
- Does a tamoxifen half-life calculator establish disappearance of all active material?
- The library's scalar represents the parent compound, and its note describes longer-persisting active metabolites. The guide's single curve does not separately model those metabolites. Even its parent-only equation leaves a nonzero fraction at the five-interval endpoint.[1][4]
- Why is six days used when the source describes five to seven days?
- The app stores 144 hours as a representative parent-compound input within that described range. A representative point simplifies visualization. It is not a claim that every measured participant or active metabolite follows exactly six days.[1][4]
- Can a peptide tracker app record Tamoxifen?
- PinPoint's compound library includes Tamoxifen. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][3]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, TamoxifenSnapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- DailyMed prescribing informationIdentity and research summary checked against this document on 5 October 2026. Clinical pharmacology and product-description sections.Retrieved 2026-10-05 · library-reference
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic